BIRC5, known as Survivin, was also part of the CTCs signature, which has been strongly associated with PCa development, progression, and drug resistance [32,33,34] and previously identified in CTCs from mCRPC by our group [14]. Here, BIRC5 is linked to posterior cortical atrophy.